|
FTO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.599130E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082210E-02 |
| Normal-vs-Stage2 |
1.235190E-01 |
| Normal-vs-Stage3 |
1.261380E-01 |
| Normal-vs-Stage4 |
6.055000E-01 |
| Stage1-vs-Stage2 |
8.057400E-01 |
| Stage1-vs-Stage3 |
8.931000E-01 |
| Stage1-vs-Stage4 |
2.083800E-01 |
| Stage2-vs-Stage3 |
9.112800E-01 |
| Stage2-vs-Stage4 |
1.648230E-01 |
| Stage3-vs-Stage4 |
2.004800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.255880E-03 |
| Normal-vs-AfricanAmerican |
2.297200E-01 |
| Normal-vs-Asian |
9.493000E-01 |
| Caucasian-vs-AfricanAmerican |
3.075400E-01 |
| Caucasian-vs-Asian |
4.260000E-01 |
| AfricanAmerican-vs-Asian |
6.355400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.836800E-03 |
| Normal-vs-Female |
1.025720E-02 |
| Male-vs-Female |
3.200000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.576200E-01 |
| Normal-vs-Extreme_Weight |
9.077600E-02 |
| Normal-vs-Obese |
1.402940E-03 |
| Normal-vs-Extreme_Obese |
4.401800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.118100E-02 |
| Normal_Weight-vs-Obese |
2.135500E-03 |
| Normal_Weight-vs-Extreme_Obese |
3.296600E-01 |
| Extreme_Weight-vs-Obese |
1.750430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.507600E-01 |
| Obese-vs-Extreme_Obese |
7.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.714800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.849960E-04 |
| Normal-vs-Age(61-80Yrs) |
1.358560E-01 |
| Normal-vs-Age(81-100Yrs) |
7.151400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.456600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.024200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.923600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.194000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.498800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.136800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.015100E-04 |
| Normal-VS-Type2 PRCC |
6.616400E-01 |
| Normal-VS-KIRP CIMP |
7.768600E-01 |
| Normal-VS-Unclassified PRCC |
3.780200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.887900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.601780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.327360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.777800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.795100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.550300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.169800E-01 |
| Normal-vs-N1 |
2.394400E-01 |
| Normal-vs-N2 |
8.557000E-01 |
| N0-vs-N1 |
5.999600E-01 |
| N0-vs-N2 |
7.320800E-01 |
| N1-vs-N2 |
5.192400E-01 |
|
|
